MARSHALL WACE, LLP - PROGENICS PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 133 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2015. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2018$58,000
-62.1%
13,985
-32.0%
0.00%
-50.0%
Q2 2015$153,000
+24.4%
20,5670.0%0.00%0.0%
Q1 2015$123,000
-20.6%
20,5670.0%0.00%0.0%
Q4 2014$155,000
-82.3%
20,567
-87.8%
0.00%
-84.6%
Q3 2014$875,000–168,657–0.01%–
 Download
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q3 2015.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders